Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

190
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVARTIS AG
12/01 NOVARTIS' : heart failure medicine LCZ696 granted accelerated assessment by CHMP..
12/01 NOVARTIS : provides update on fingolimod Phase III trial in primary progressive ..
12/01 NOVARTIS : provides update on fingolimod Phase III trial in primary progressive ..
12/01 NOVARTIS : BioPharm Insight Issues Hematological Cancer Report in Advance of Ame..
11/30 GSK TO AXE U.S. JOBS AS PART OF $1.6 : sources
11/28 NOVARTIS : Suspicious post-flu vaccine death reported in Parma - update
11/28 NOVARTIS : Flu vaccine raises concerns across Italy after deaths
11/28 NOVARTIS : Italy pulls 2 batches of Novartis flu vaccine as a precaution followi..
11/28 NOVARTIS : Italian pulls flu vaccine following deaths
11/28 Switzerland moves to boost number of women executives
11/28 NOVARTIS : Siena prosecutor to investigate flu vaccine
11/28 Germany's Merck aims to grow, not sell $1 billion consumer health arm
11/28 NOVARTIS : Flu vaccine link ruled out in Prato death - update
11/28 NOVARTIS : ++ Fourth death linked to halted flu vaccine ++
11/28 NOVARTIS : Fourth death linked to halted flu vaccine - report - update
11/28 NOVARTIS : ' heart failure medicine LCZ696 granted accelerated assessment by CHM..
11/28 NOVARTIS' : heart failure medicine LCZ696 granted accelerated assessment by CHMP..
11/27 NOVARTIS : ++ Two suspicious flu vaccine deaths near Siracusa ++
11/27 NOVARTIS : FTC Puts Conditions on Pharmaceutical Joint Venture Between GlaxoSmit..
11/27 NOVARTIS : Commission grants clearance to consumer pharmaceutical merger
11/27 NOVARTIS : GSK -Regulatory update on transaction with Novartis
11/27 NOVARTIS : FTC Puts Conditions on Pharmaceutical Joint Venture Between GlaxoSmit..
11/27 Glaxo's Deal With Novartis Is Approved By US Regulator FTC
11/26 NOVARTIS : Trademark Application for "IT TASTES AWFUL. AND IT WORKS." Filed by N..
11/26 NOVARTIS : An Application for the Trademark "IT TASTES AWFUL. IT WORKS." Has Bee..
11/26 NOVARTIS : Diovan Case Study: How to Become a Leader in a Crowded Marketplace
11/26 Medtronic gets U.S. antitrust OK to buy Covidien with divestiture
11/26 NOVARTIS : AIN457 secukinumab showed significant symptom improvement in two pivo..
11/26 U.S. approves GSK's purchase of Novartis vaccine business - companies
11/26 Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal - FT..
11/26DJNovartis to Divest Nicotine Patch Habitrol to Comply with FTC
11/25 NOVARTIS : European Commission approves Novartis' Signifor to treat patients wit..
11/25 NOVARTIS : Tata Memorial to repay cancer patients
11/25 NOVARTIS : MILITARY $19,207 Federal Contract Awarded to Alcon Laboratories
11/25 NOVARTIS : Alcon Research Assigned Patent
11/25 GLAXOSMITHKLINE : calls investors to vote for trade with Novartis
11/25 NOVARTIS : announces extension to FDA review period for multiple myeloma investi..
11/25 NOVARTIS : announces extension to FDA review period for multiple myeloma investi..
11/24 GLAXOSMITHKLINE : GSK shareholders to vote on Novartis deal on Dec. 18
11/24 VECTURA : Interim Results for the six months ended 30 September 2014
11/24 NOVARTIS : Foundation symposium showcases sustainable healthcare interventions
11/24 NOVARTIS : Foundation symposium showcases sustainable healthcare interventions
11/24 NOVARTIS : Cosentyx receives positive CHMP opinion for first-line treatment of m..
11/24 GSK shareholders to vote on Novartis deal on Dec. 18
11/24 GSK shareholders to vote on Novartis deal on December 18
11/24 NOVARTIS : drug Signifor® approved in EU, marking an advance for patients with i..
11/24 NOVARTIS : drug Signifor® approved in EU, marking an advance for patients with i..
11/24 NOVARTIS : Qiagen Enters Collaboration Pact with Novartis
11/22 NOVARTIS : MILITARY Infinity Phaco Custom Paks Sought by U.S. Navy
11/21 NOVARTIS : CCP opens second phase review on proposed acquisition of vaccines bus..
11/21 NOVARTIS : CCP opens second phase review of proposed acquisition
11/21 NOVARTIS : CCP opens second phase review on proposed acquisition of vaccines bus..
11/21 NOVARTIS : CCP opens 2nd phase review for proposed GSK acquisition
11/21 Weary of the market rollercoaster, investors turn again to steady stocks
11/21 NOVARTIS INDIA : Bt500 rankings: india's most valuable top-500 companies - novar..
11/21 NOVARTIS : Two northern Lincolnshire firms are celebrated
11/21DJNOVARTIS : Psoriasis Treatment Recommended for Approval by CHMP
11/21 NOVARTIS : Foundation symposium showcases sustainable healthcare interventions »
11/21 NOVARTIS : Foundation symposium showcases sustainable healthcare interventions
11/21 NOVARTIS : Cosentyx(TM) receives positive CHMP opinion for first-line treatment ..
11/21 NOVARTIS : Foundation symposium showcases sustainable healthcare interventions
11/21 NOVARTIS : Cosentyx(TM) receives positive CHMP opinion for first-line treatment ..
11/21 SEC director with big stock holdings stirs debate
11/19 NOVARTIS : Researchers Submit Patent Application, "Pharmaceutical Combinations C..
11/19 NOVARTIS : to present first IL-17A Phase III data for AIN457 secukinumab in psor..
11/19 NOVARTIS : Patent Issued for Silicone-Containing Polymeric Materials with Hydrol..
11/19 NOVARTIS : Patent Issued for Methods for Increasing the Ion Permeability of Cont..
11/19 NOVARTIS : "Treatment of Hypertension And/Or Prevention Or Treatment of Heart Fa..
11/19 VECTURA : Gets Milestone Payment After Asthma Inhaler's Latest Approvals
11/18 NOVARTIS : A Family's Reaction to Meningococcal B Vaccination Becoming Available..
11/18 NOVARTIS : takes aim at tech
11/17 NOVARTIS : Nine new analyses show Novartis' LCZ696 could change course of heart ..
11/17 NOVARTIS : Nine new analyses show Novartis' LCZ696 could change course of heart ..
11/17 NOVARTIS : Nine new analyses show Novartis' LCZ696 could change course of heart ..
11/17 NOVARTIS : presents ground-breaking Phase III results showing AIN457 (secukinuma..
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF